Comparison of Medical and Mental Health Sequelae Following Hospitalization for COVID-19, Influenza, and Sepsis.


Journal

JAMA internal medicine
ISSN: 2168-6114
Titre abrégé: JAMA Intern Med
Pays: United States
ID NLM: 101589534

Informations de publication

Date de publication:
01 08 2023
Historique:
pmc-release: 20 06 2024
medline: 8 8 2023
pubmed: 20 6 2023
entrez: 20 6 2023
Statut: ppublish

Résumé

People who survive hospitalization for COVID-19 are at risk for developing new cardiovascular, neurological, mental health, and inflammatory autoimmune conditions. It is unclear how posthospitalization risks for COVID-19 compare with those for other serious infectious illnesses. To compare risks of incident cardiovascular, neurological, and mental health conditions and rheumatoid arthritis in 1 year following COVID-19 hospitalization against 3 comparator groups: prepandemic hospitalization for influenza and hospitalization for sepsis before and during the COVID-19 pandemic. This population-based cohort study included all adults hospitalized for COVID-19 between April 1, 2020, and October 31, 2021, historical comparator groups of people hospitalized for influenza or sepsis, and a contemporary comparator group of people hospitalized for sepsis in Ontario, Canada. Hospitalization for COVID-19, influenza, or sepsis. New occurrence of 13 prespecified conditions, including cardiovascular, neurological, and mental health conditions and rheumatoid arthritis, within 1 year of hospitalization. Of 379 366 included adults (median [IQR] age, 75 [63-85] years; 54% female), there were 26 499 people who survived hospitalization for COVID-19, 299 989 historical controls (17 516 for influenza and 282 473 for sepsis), and 52 878 contemporary controls hospitalized for sepsis. Hospitalization for COVID-19 was associated with an increased 1-year risk of venous thromboembolic disease compared with influenza (adjusted hazard ratio, 1.77; 95% CI, 1.36-2.31) but with no increased risks of developing selected ischemic and nonischemic cerebrovascular and cardiovascular disorders, neurological disorders, rheumatoid arthritis, or mental health conditions compared with influenza or sepsis cohorts. In this cohort study, apart from an elevated risk of venous thromboembolism within 1 year, the burden of postacute medical and mental health conditions among those who survived hospitalization for COVID-19 was comparable with other acute infectious illnesses. This suggests that many of the postacute consequences of COVID-19 may be related to the severity of infectious illness necessitating hospitalization rather than being direct consequences of infection with SARS-CoV-2.

Identifiants

pubmed: 37338892
pii: 2806192
doi: 10.1001/jamainternmed.2023.2228
pmc: PMC10282961
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

806-817

Subventions

Organisme : CIHR
ID : CIHR GA4-177772
Pays : Canada

Auteurs

Kieran L Quinn (KL)

Department of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
ICES, Toronto and Ottawa, Ontario, Canada.
Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
Department of Medicine, Sinai Health and University Health Network, Toronto, Ontario, Canada.
Temmy Latner Centre for Palliative Care, Toronto, Ontario, Canada.

Thérèse A Stukel (TA)

ICES, Toronto and Ottawa, Ontario, Canada.
Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.

Anjie Huang (A)

ICES, Toronto and Ottawa, Ontario, Canada.

Husam Abdel-Qadir (H)

Department of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
ICES, Toronto and Ottawa, Ontario, Canada.
Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
Women's College Hospital, University of Toronto, Toronto, Ontario, Canada.
Peter Munk Cardiac Centre, University Health Network, Toronto, Ontario, Canada.

Azmina Altaf (A)

ICES, Toronto and Ottawa, Ontario, Canada.

Chaim M Bell (CM)

Department of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
ICES, Toronto and Ottawa, Ontario, Canada.
Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
Department of Medicine, Sinai Health and University Health Network, Toronto, Ontario, Canada.

Angela M Cheung (AM)

Department of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
ICES, Toronto and Ottawa, Ontario, Canada.

Allan S Detsky (AS)

Department of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
Department of Medicine, Sinai Health and University Health Network, Toronto, Ontario, Canada.

Susie Goulding (S)

COVID Long-Haulers Canada, Oakville, Ontario, Canada.

Margaret Herridge (M)

Department of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
ICES, Toronto and Ottawa, Ontario, Canada.

Noah Ivers (N)

Women's College Hospital, University of Toronto, Toronto, Ontario, Canada.

Lauren Lapointe-Shaw (L)

Department of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
ICES, Toronto and Ottawa, Ontario, Canada.
Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
Department of Medicine, Sinai Health and University Health Network, Toronto, Ontario, Canada.

John Lapp (J)

Department of Medicine, Sinai Health and University Health Network, Toronto, Ontario, Canada.

Candace D McNaughton (CD)

Department of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
ICES, Toronto and Ottawa, Ontario, Canada.
Sunnybrook Research Institute, Toronto, Ontario, Canada.

Afsaneh Raissi (A)

Li Ka Shing Knowledge Institute, Unity Health Toronto, Department of Medicine, Toronto, Ontario, Canada.
Unity Health Toronto, Department of Medicine, St Michael's Hospital, Toronto, Ontario, Canada.

Laura C Rosella (LC)

ICES, Toronto and Ottawa, Ontario, Canada.
Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.

Nahrain Warda (N)

Department of Medicine, Sinai Health and University Health Network, Toronto, Ontario, Canada.

Fahad Razak (F)

Department of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
Li Ka Shing Knowledge Institute, Unity Health Toronto, Department of Medicine, Toronto, Ontario, Canada.
Unity Health Toronto, Department of Medicine, St Michael's Hospital, Toronto, Ontario, Canada.

Amol A Verma (AA)

Department of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
Li Ka Shing Knowledge Institute, Unity Health Toronto, Department of Medicine, Toronto, Ontario, Canada.
Unity Health Toronto, Department of Medicine, St Michael's Hospital, Toronto, Ontario, Canada.
Temerty Centre for AI Research and Education in Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH